Rekha Hemrajani, Director at ALX ONCOLOGY HOLDINGS INC (ALXO), bought 30,000 shares at $1.55 ($47K) on 2024-12-02, disclosed to the SEC on 2024-12-04.
Open-market purchase of $46k ALXO by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Something here stands out, but not much.
| Filing → |
| ALXO | BUY | 2020-07-21 | $57K | — | Filing → |